(Q37288770)

19 August 2017

title

Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

1 reference

Udaya M Kabadi

1

1 reference

19 August 2017

publication date

1 January 2008

1 reference

Clinical Drug Investigation

19 August 2017

published in

1 reference

19 August 2017

volume

28

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

697-701

1 reference

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

19 August 2017

cites work

1 reference

12 December 2020

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

1 reference

12 December 2020

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Diabetic complications. The importance of glucose control

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort

1 reference

12 December 2020

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy

1 reference

12 December 2020

The cost to health plans of poor glycemic control

1 reference

12 December 2020

10.2165/00044011-200828110-00003

Identifiers

DOI

1 reference

19 August 2017

1 reference